Bluprynt | $4,250,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
Revel(US) | $150,000,000 | (Feb 27, 2026)
Certified by Founder
Lodge
Nephron Pharmaceuticals
start up
United States
- West Columbia, South Carolina
- 18/09/2023
- Unknown
- $350,000,000
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD.
- Industry Pharmaceutical Manufacturing
- Website https://www.nephronpharm.com/
- LinkedIn https://www.linkedin.com/company/nephron-pharm/about/
Alpa | $3,500,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
Callosum | $10,250,000 | (Feb 27, 2026)
JetScale AI | $5,400,000 | (Feb 27, 2026)
Dots | $8,900,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
Ark Climate | $2,478,315 | (Feb 27, 2026)
Jest | $7,000,000 | (Feb 27, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)